Overview

Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and Forehead

Status:
NOT_YET_RECRUITING

Trial end date:
2027-11-30

Target enrollment:

Participant gender:

Summary

The aim of the study is to evaluate the efficacy and safety of a combined approach of cryotherapy and tirbanibulin for the treatment of actinic keratosis of the scalp and forehead, repeated every 4 months. A higher rate of complete response is expected with this combination compared to cryotherapy alone, as well as a better response with repeated treatment cycles.

Phase:

PHASE3

Details

Lead Sponsor:

University Hospital, Lille

Collaborator:

Almirall, SAS

Treatments:

Cryotherapy
tirbanibulin